|
N (%)
|
135 (67.5%)
|
65 (32.5%)
|
-
|
|
Age (mean ± SD) years
|
52.46 ± 8.09
|
71.82 ± 6.03
|
<0.0001
|
|
Female gender
|
30 (22.2%)
|
29 (44.6%)
|
0.001
|
|
Hypertension
|
84 (62.2%)
|
55 (84.6%)
|
0.001
|
|
Diabetes
|
58 (43%)
|
40 (61.5%)
|
0.014
|
|
IHD
|
57 (42.2%)
|
39 (60%)
|
0.018
|
|
Family history
|
44 (32.6%)
|
21 (32.3%)
|
0.9
|
|
Smoking
|
57 (42.2%)
|
12 (18.5%)
|
0.001
|
|
Hyperlipidaemia
|
26 (19.3%)
|
19 (29.2%)
|
0.1
|
|
Stroke
|
3 (2.2%)
|
3 (4.6%)
|
0.3
|
|
Atrial fibrillation (new or old)
|
9 (6.7%)
|
8 (12.3%)
|
0.1
|
|
Prior catheterization
|
9 (6.7%)
|
8 (12.3%)
|
0.18
|
|
Prior PCI
|
14 (21.5%)
|
21 (15.6%)
|
0.29
|
|
Prior CABG
|
1 (0.7%)
|
4 (6.2%)
|
0.02
|
|
Dyspnoea
|
34 (25.2%)
|
25 (38.5%)
|
0.054
|
|
Positive troponin
|
57 (42.2%)
|
36 (55.4%)
|
0.08
|
|
Pulse rate (mean ± SD) BPM
|
84.3 ± 21.5
|
85.8 ± 22.3
|
0.6
|
|
SBP (mean ± SD) mmHg
|
135.3 ± 24.3
|
139 ± 27.4
|
0.3
|
|
DBP (mean ± SD) mmHg
|
82.2 ± 13.2
|
79.03 ± 11.7
|
0.09
|
|
Ejection fraction
|
54.8 ± 11.6
|
51.6 ± 11.9
|
0.1
|
|
Blood sugar
|
182.6 ± 110.1
|
197.08 ± 109.9
|
0.4
|
|
Urea (mean ± SD) mg/dL
|
35.6 ± 15.05
|
47.2 ± 20.6
|
<0.0001
|
|
Creatinine (mean ± SD) Mg/dL
|
0.9 ± 0.3
|
1.04 ± 0.3
|
0.01
|
|
Estimated GFRa (mean ± SD) ml/min/1.73 m2
|
90.75 ± 20.11
|
67.4 ± 20.13
|
<0.0001
|
|
Haemoglobin (mean ± SD) gm/L
|
13.7 ± 2.06
|
12.7 ± 1.9
|
0.006
|
|
WBC (mean ± SD) × 103/mcL
|
9.369 ± 3.027
|
9.362 ± 2.859
|
0.9
|
|
Platelets count (mean ± SD)/mcL
|
235020 ± 77.075
|
236250 ± 76.375
|
0.9
|
|
Hospitalization duration (mean ± SD) days
|
4.9 ± 2.7
|
4.8 ± 2.8
|
0.7
|
|
GRACE risk class
|
|
Low
|
75 (55.6%)
|
9 (13.8%)
|
<0.0001
|
|
Intermediate
|
39 (28.9%)
|
12 (18.5%)
|
|
High
|
21 (15.6%)
|
44 (67.7%)
|
